Paving the Way to a Brighter Future
Our regenerative therapy aims to meet this clinical need and offer a treatment, not only for the refractory group of patients for whom medical therapy, angioplasty and coronary bypass surgery have failed to control the disease, but also for patients much earlier in the treatment pathway.
Genetic opportunities for disease therapy
The aim of treating CAD with gene therapy is to cause regenerative changes and to improve myocardial blood flow. Therapeutic vascular growth is a new concept for the treatment of ischemic vascular diseases. It involves stimulation of angiogenesis, arteriogenesis, and induction of regenerative changes via activation of stem/progenitors cells.